Rahee Mapara
NHS Greater Glasgow and Clyde
5 Papers
4 Citations
Rahee Mapara is an academic researcher from NHS Greater Glasgow and Clyde. The author has contributed to research in topics: Internal medicine & Chemotherapy. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
144 The Burden of Harm of a Long Wait Time for Laparoscopic Cholecystectomy; the Experience of a National Referral Centre
Rahee Mapara,Maciej Meszka,Eve Watt,Erin McIlveen +3 more
160 The Patient Experience of Laparoscopic Cholecystectomy as a Day Case at a National Referral Centre; a 7 Month Evaluation of Outcomes
Maciej Meszka,Eve Watt,Rahee Mapara,Erin McIlveen +3 more
TL;DR: A 7-month retrospective analysis of 191 laparoscopic cholecystectomy patients at a national referral centre in Scotland found variable waiting times, 5.2% pre-operative biliary admissions, and 2 post-operative complications, highlighting safety and cost implications.
Magseed localised TAD for node positive patients following neoadjuvant chemotherapy in Glasgow
Louise J. Magill,Rahee Mapara,Katherine Duncan,Laura Arthur,Sophia Sakellariou,James Mansell,Jennifer Campbell,A Seth,Joseph Loane,Christopher Wilson,D. Doughty,László Romics +11 more
TL;DR: Magseed localised targeted axillary dissection (mTAD) is associated with decreased false negative rates in patients with node positive disease undergoing neoadjuvant chemotherapy (NAC) as mentioned in this paper .
Outcomes for TAD/SLNB compared to ANC in node positive patients following neoadjuvant chemotherapy
Louise J. Magill,A. Ingham,Rahee Mapara,Katherine Duncan,Sophia Sakellariou,James Mansell,Jennifer Campbell,Laura Arthur,Archana Seth,Joseph Loane,Christopher Wilson,D. Doughty,László Romics +12 more
TL;DR: In this paper , Radiological response following neoadjuvant chemotherapy (NAC) in node positive patients provides guidance to select those patients who may be suitable for targeted axillary dissection (TAD).